Delivery Order SPE2DX22D0010-SPE2D826FAV19
- Not listed
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl Transdermal Patch 37.5 micrograms, with a ceiling value of $1,934.74. The contract, awarded on July 25, 2025, employs firm fixed-price pricing and is scheduled for completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,089.77 for fentanyl transdermal patches (37.5 mcg) under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The award, issued on September 12, 2025, carries an ultimate completion date of September 15, 2025, and represents a non-competitive, non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.15 to AmerisourceBergen Drug Corp for the supply of Fentanyl 37.5 micrograms per hour patches (quantity 5) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and was awarded competitively. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 micrograms per hour transdermal patches (5-count units) on September 3, 2025, with a ceiling value of $1,220.08. The contract operates under firm fixed-price terms with an ultimate completion date of September 4, 2025. This delivery order is issued without a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $7,037.29 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 mcg/hr patches (5 count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fentanyl Transdermal Patches, 37.5 mcg, with a ceiling value of $1,979.46 and an ultimate completion date of March 27, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fentanyl Transdermal Patches, a specialized pain management medication, to support military healthcare programs. The contract has a ceiling value of $1,291.71 and an ultimate completion date of January 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Fentanyl 100 micrograms per 2 milliliter vials with a ceiling value of $1,327.86. This is a firm fixed-price delivery order with an ultimate completion date of July 17, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a $1,162.00 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Fentanyl 2,500 micrograms per 50 milliliter vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,804.87 firm-fixed-price delivery order is for the supply of 4565884446 Fentanyl Transdermal Patches at 37.5 mcg. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger indefinite delivery contract valued up to $999,999,999 with the DLA...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAV19Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Fentanyl Transdermal Patch 62.5 micrograms. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,478.45 with an ultimate completion date of November 5, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, positions the company as a critical vendor for federal medical procurement needs across Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 11/4/25 |